Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11815776.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systemic onset juvenile rheumatoid arthritis unresponsive to nonsteroidal anti-inflammatory drugs may be controlled with corticosteroids, but these drugs have significant side effects. We report 2 steroid-dependent children with systemic onset juvenile rheumatoid arthritis who did not respond to multiple nonsteroidal anti-inflammatory drugs, methotrexate, azathioprine, cyclosporine, and etanercept. Both children had significant improvement with thalidomide therapy.
Medical subject headings
- Arthritis, Juvenile
- Thalidomide